CN102448455A - 类黄酮用于提高橙皮素的生物利用度的用途 - Google Patents

类黄酮用于提高橙皮素的生物利用度的用途 Download PDF

Info

Publication number
CN102448455A
CN102448455A CN2010800226972A CN201080022697A CN102448455A CN 102448455 A CN102448455 A CN 102448455A CN 2010800226972 A CN2010800226972 A CN 2010800226972A CN 201080022697 A CN201080022697 A CN 201080022697A CN 102448455 A CN102448455 A CN 102448455A
Authority
CN
China
Prior art keywords
hesperetin
use according
compound
treatment
flavonoid compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800226972A
Other languages
English (en)
Chinese (zh)
Inventor
W·布兰德
G·威廉森
P·范布拉德伦
I·M·C·M·利特珍斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Societe dAssistance Technique pour Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40908614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102448455(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe dAssistance Technique pour Produits Nestle SA filed Critical Societe dAssistance Technique pour Produits Nestle SA
Publication of CN102448455A publication Critical patent/CN102448455A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
CN2010800226972A 2009-03-31 2010-03-30 类黄酮用于提高橙皮素的生物利用度的用途 Pending CN102448455A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09156910.3 2009-03-31
EP09156910A EP2241313A1 (en) 2009-03-31 2009-03-31 Use of flavonoids to increase the bioavailability of hesperetin
PCT/EP2010/054215 WO2010112510A1 (en) 2009-03-31 2010-03-30 Use of flavonoids to increase the bioavailability of hesperetin

Publications (1)

Publication Number Publication Date
CN102448455A true CN102448455A (zh) 2012-05-09

Family

ID=40908614

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800226972A Pending CN102448455A (zh) 2009-03-31 2010-03-30 类黄酮用于提高橙皮素的生物利用度的用途

Country Status (11)

Country Link
US (1) US8685935B2 (enExample)
EP (2) EP2241313A1 (enExample)
JP (1) JP2012522030A (enExample)
CN (1) CN102448455A (enExample)
AR (1) AR076040A1 (enExample)
AU (1) AU2010230211A1 (enExample)
BR (1) BRPI1014083A2 (enExample)
CL (1) CL2011002451A1 (enExample)
MX (1) MX2011010376A (enExample)
SG (1) SG174609A1 (enExample)
WO (1) WO2010112510A1 (enExample)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697768A (zh) * 2012-06-07 2012-10-03 中国人民解放军第二军医大学 一类木犀草素类似黄酮类化合物在制备抗肿瘤药物中的用途
CN102861092A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid C在治疗肺癌药物中的应用
CN102861046A (zh) * 2012-10-27 2013-01-09 南京大学 Houttuynoid A在治疗卵巢癌药物中的应用
CN102861090A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid C在治疗胆管癌药物中的应用
CN102861075A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid B在治疗胃癌药物中的应用
CN102861060A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid B在治疗白血病药物中的应用
CN102861048A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid A在治疗鼻咽癌药物中的应用
CN102861050A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid A在治疗胰腺癌药物中的应用
CN102861086A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid E在治疗卵巢癌药物中的应用
CN102861081A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid C在治疗皮肤癌药物中的应用
CN103462957A (zh) * 2012-06-07 2013-12-25 上海中医药大学 一种异鼠李素的新用途
CN104869848A (zh) * 2012-11-29 2015-08-26 雀巢产品技术援助有限公司 用多酚增加黄烷-3-醇的生物利用度
CN104983728A (zh) * 2015-08-07 2015-10-21 上海中医药大学 金合欢素在制备防治溃疡性结肠炎的药物或食品中的应用
CN105167193A (zh) * 2015-06-17 2015-12-23 湖北中烟工业有限责任公司 含黄酮香精的烟用嘴棒及其制备方法
CN108472307A (zh) * 2015-12-29 2018-08-31 延世大学校产学协力团 包含香叶木甙作为有效成分的用于预防或治疗脱发或用于促进生发或育发的组合物
CN111281866A (zh) * 2020-03-30 2020-06-16 中国药科大学 一种预防或治疗溃疡性结肠炎的中药化学制剂
CN112569246A (zh) * 2020-12-22 2021-03-30 成都大学 用于抗炎镇痛止血的药物及药物活性组分筛选方法
CN113679733A (zh) * 2021-08-31 2021-11-23 广东金骏康生物技术有限公司 一种抑制结肠炎的化合物及其应用
CN114948977A (zh) * 2021-02-25 2022-08-30 南京中医药大学 二氢黄酮苷衍生物在制备防治结肠炎的药物中的用途

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100234310A1 (en) * 2009-03-11 2010-09-16 Bionovo, Inc. Estrogenic compounds and their methods of use
US9053152B2 (en) 2012-08-06 2015-06-09 Sap Portals Israel Ltd Search and context based creation in dynamic workspaces
CN102861053B (zh) * 2012-10-27 2013-07-10 南京大学 Houttuynoid D在治疗白血病药物中的应用
GB201407694D0 (en) * 2014-05-01 2014-06-18 Univ Montfort Compound
WO2016128503A1 (en) * 2015-02-11 2016-08-18 Bioactor Bv Compounds and compositions for improving power output and oxygen efficiency
US12257231B2 (en) * 2015-02-13 2025-03-25 Global Biolife Inc. Method and composition for preventing and treating viral infections
US10383842B2 (en) * 2015-02-13 2019-08-20 Global Biolife Inc. Method and composition for preventing and treating viral infections
JP6881890B2 (ja) * 2015-05-14 2021-06-02 花王株式会社 カテキン類吸収促進剤
US10123991B2 (en) * 2015-05-15 2018-11-13 Global Biolife Inc. Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders
US20220249530A1 (en) * 2017-08-28 2022-08-11 Global Biolife Inc. Method and composition for preventing and treating viral infections
US11311563B2 (en) * 2017-08-28 2022-04-26 Global Biolife Inc. Method and composition for preventing and treating viral infections
JP2019151568A (ja) * 2018-03-01 2019-09-12 アサヒ飲料株式会社 酸性スフィンゴミエリナーゼ活性向上剤、酸性スフィンゴミエリナーゼ活性向上用組成物、及び抗アレルギー用組成物
KR20200091271A (ko) * 2019-01-22 2020-07-30 조선대학교산학협력단 헤스페레틴을 포함하는 피부과민반응을 조절하기 위한 조성물
KR20210021827A (ko) 2019-08-19 2021-03-02 연세대학교 산학협력단 켐페라이드를 유효성분으로 포함하는 대사질환의 예방 또는 치료용 조성물
CN113440514B (zh) * 2021-08-20 2022-09-09 中国农业科学院郑州果树研究所 含橙皮素的组合物及其制备降血糖药物的应用
EP4205608B1 (en) * 2021-11-16 2025-12-31 DAITO Entertainment, Inc. COFFEE MACHINE
CN117224530A (zh) * 2023-09-15 2023-12-15 北京东方百奥医药开发有限公司 一种改善雄性哺乳动物睾酮水平的化合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283154A (ja) * 1995-04-12 1996-10-29 Nippon Shinyaku Co Ltd 脂質代謝改善剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6666594A (en) 1993-04-20 1994-11-08 Procter & Gamble Company, The Methods of using hesperetin for sebum control and treatment of acne
JP4846141B2 (ja) * 2001-08-31 2011-12-28 東洋精糖株式会社 即効性および持続性を有するフラボノイド配糖体を含有する経口栄養補給剤
WO2003043570A2 (en) * 2001-11-15 2003-05-30 Galileo Laboratories, Inc. Formulations and methods for treatment or amelioration of inflammatory conditions
JP5419366B2 (ja) * 2008-03-03 2014-02-19 東洋精糖株式会社 生体吸収性に優れたヘスペレチン組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283154A (ja) * 1995-04-12 1996-10-29 Nippon Shinyaku Co Ltd 脂質代謝改善剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SHUZHONG ZHANG等: "Combined Effects of Multiple Flavonoids on Breast Cancer Resistance Protein (ABCG2)-Mediated Transport", 《PHARMACEUTICAL RESEARCH》 *
WALTER BRAND等: "Metabolism and Transport of the Citrus Flavonoid Hesperetin in Caco-2 Cell Monolayers", 《DRUG METABOLISM AND DISPOSITION》 *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697768A (zh) * 2012-06-07 2012-10-03 中国人民解放军第二军医大学 一类木犀草素类似黄酮类化合物在制备抗肿瘤药物中的用途
CN103462957A (zh) * 2012-06-07 2013-12-25 上海中医药大学 一种异鼠李素的新用途
CN102861060A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid B在治疗白血病药物中的应用
CN102861090A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid C在治疗胆管癌药物中的应用
CN102861075A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid B在治疗胃癌药物中的应用
CN102861046A (zh) * 2012-10-27 2013-01-09 南京大学 Houttuynoid A在治疗卵巢癌药物中的应用
CN102861048A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid A在治疗鼻咽癌药物中的应用
CN102861050A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid A在治疗胰腺癌药物中的应用
CN102861086A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid E在治疗卵巢癌药物中的应用
CN102861081A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid C在治疗皮肤癌药物中的应用
CN102861092A (zh) * 2012-10-27 2013-01-09 吴俊华 Houttuynoid C在治疗肺癌药物中的应用
CN104869848A (zh) * 2012-11-29 2015-08-26 雀巢产品技术援助有限公司 用多酚增加黄烷-3-醇的生物利用度
CN104869848B (zh) * 2012-11-29 2020-04-10 雀巢产品有限公司 用多酚增加黄烷-3-醇的生物利用度
CN105167193A (zh) * 2015-06-17 2015-12-23 湖北中烟工业有限责任公司 含黄酮香精的烟用嘴棒及其制备方法
CN105167193B (zh) * 2015-06-17 2019-02-19 湖北中烟工业有限责任公司 含黄酮香精的烟用嘴棒及其制备方法
CN104983728A (zh) * 2015-08-07 2015-10-21 上海中医药大学 金合欢素在制备防治溃疡性结肠炎的药物或食品中的应用
CN108472307A (zh) * 2015-12-29 2018-08-31 延世大学校产学协力团 包含香叶木甙作为有效成分的用于预防或治疗脱发或用于促进生发或育发的组合物
CN111281866A (zh) * 2020-03-30 2020-06-16 中国药科大学 一种预防或治疗溃疡性结肠炎的中药化学制剂
CN111281866B (zh) * 2020-03-30 2021-09-28 中国药科大学 一种预防或治疗溃疡性结肠炎的中药化学制剂
CN112569246A (zh) * 2020-12-22 2021-03-30 成都大学 用于抗炎镇痛止血的药物及药物活性组分筛选方法
CN114948977A (zh) * 2021-02-25 2022-08-30 南京中医药大学 二氢黄酮苷衍生物在制备防治结肠炎的药物中的用途
CN114948977B (zh) * 2021-02-25 2023-11-28 南京中医药大学 二氢黄酮苷衍生物在制备防治结肠炎的药物中的用途
CN113679733A (zh) * 2021-08-31 2021-11-23 广东金骏康生物技术有限公司 一种抑制结肠炎的化合物及其应用

Also Published As

Publication number Publication date
SG174609A1 (en) 2011-10-28
EP2413928A1 (en) 2012-02-08
EP2241313A1 (en) 2010-10-20
WO2010112510A1 (en) 2010-10-07
BRPI1014083A2 (pt) 2016-04-19
JP2012522030A (ja) 2012-09-20
US20120022010A1 (en) 2012-01-26
AR076040A1 (es) 2011-05-11
CL2011002451A1 (es) 2012-04-20
MX2011010376A (es) 2011-10-12
US8685935B2 (en) 2014-04-01
AU2010230211A1 (en) 2011-11-03

Similar Documents

Publication Publication Date Title
CN102448455A (zh) 类黄酮用于提高橙皮素的生物利用度的用途
Rudrapal et al. Dietary polyphenols: review on chemistry/sources, bioavailability/metabolism, antioxidant effects, and their role in disease management
Cannataro et al. Polyphenols in the Mediterranean diet: from dietary sources to microRNA modulation
Salehi et al. Hesperetin’s health potential: Moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations
Wang et al. Protocatechuic acid, a metabolite of anthocyanins, inhibits monocyte adhesion and reduces atherosclerosis in apolipoprotein E-deficient mice
Lee et al. Pharmacokinetics of quercetin absorption from apples and onions in healthy humans
Alexander et al. Role of herbal bioactives as a potential bioavailability enhancer for active pharmaceutical ingredients
Lee et al. Recent advances on the beneficial use and health implications of Pu-Erh tea
US9211298B2 (en) Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
ES2863561T3 (es) Fitocomplejos de Citrus bergamia
Lockyer et al. Olive leaf phenolics and cardiovascular risk reduction: physiological effects and mechanisms of action
Janigashvili et al. Effects and medical application of plant-origin polyphenols: A narrative review
Shi et al. Recent advances in the health benefits and application of tangerine peel (Citri Reticulatae Pericarpium): A review
Li et al. Dietary flavonoid quercetin supplement promotes antiviral innate responses against vesicular stomatitis virus infection by reshaping the bacteriome and host metabolome in mice
Patel et al. Phytochemical and pharmacological profile of Malus domestica: an overview
Chang et al. Structurally related anticancer activity of flavonoids: involvement of reactive oxygen species generation
Lee et al. Antioxidant activity of isolated compounds from the shoot of Aralia elata Seem
AU2015221487A1 (en) Use of flavonoids to increase the bioavailability of hesperetin
CN102205010A (zh) 一种具有辅助降血脂功能的药物组合物
Hameed et al. Resveratrol: Properties, Sources, Production and Their Medical Applications A Review
Raju et al. Antitumor activity of ethanol and aqueous extracts of Drosera Burmannii vahl. İn EAC Bearing Mice
Singh et al. Current and future prospects of flavonoids for human immune system
KR20190038551A (ko) 마이크로rna(mirna)를 통한 유익한 유전자 조절이 가능한 종합비타민
Mansoori et al. A comprehensive review on biological activity of green tea (Camellia sinensis)
Cesa et al. Polyphenols and Flavonoids: Chemical, Pharmacological and Therapeutic Aspects

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120509